cannabis indica

TEPT

termo de indexação original: PTSD

O acervo do Cannabis Indica reúne 161 estudos científicos que tocam a condição TEPT, publicados entre 2002 e 2024. Pela leitura automatizada, 116 (72%) foram classificados como favoráveis, 24 (15%) como inconclusivos e 21 (13%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (90 estudos), seguido de estudo em animais (25). Os compostos mais presentes são Anandamida (AEA), Endocanabinoide (não especificado) e 2-Araquidonoilglicerol (2-AG). Aparece com frequência ao lado de Ansiedade, Depressão e Dependência — Cannabis.

Estudos indexados
161
Período coberto
2002–2024
Favoráveis
116 · 72%
Inconclusivos
24 · 15%
Desfavoráveis
21 · 13%
Termo original
PTSD

O acervo em números

Tipo de estudo

Metanálise90
Estudo em Animais25
Ensaio Clínico22
Ensaio Clínico Duplo-Cego16
Metanálise Clínica7
Estudo Laboratorial1

Direção do resultado

Favorável116
Inconclusivo24
Desfavorável21

Por década

2000s6
2010s56
2020s99

161 estudos

Filtrar e buscar no acervo →
  1. 2024

    Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoInsônia e Distúrbios do Sono+2
  2. 2024

    Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis

    FavorávelMetanálise Clínica
  3. 2023

    A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History

    DesfavorávelMetanáliseDorCâncerInflamaçãoTetraidrocanabinol (THC)Canabigerol (CBG)+13
  4. 2023

    A small clinical trial of vaporized cannabis for PTSD: suggestive results and directions for future study

    FavorávelEnsaio Clínico Duplo-Cego
  5. 2023

    Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review

  6. 2023

    Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs

    FavorávelMetanálise
  7. 2023

    Factors associated with suicide in people who use drugs: a scoping review

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+10
  8. 2023

    Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials

    DesfavorávelMetanálise
  9. 2023

    Involvement of cannabinoid receptors and neuroinflammation in early sepsis: Implications for posttraumatic stress disorder

  10. 2023

    Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

    FavorávelMetanáliseDorCâncerDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+16
  11. 2023

    Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

  12. 2023

    Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics

  13. 2023

    The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study

    FavorávelMetanáliseAnsiedadeDepressãoNáusea e Vômito+1
  14. 2023

    The Effects of Pharmacological Treatment of Nightmares: A Systematic Literature Review and Meta-Analysis of Placebo-Controlled, Randomized Clinical Trials

  15. 2022

    Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1

  16. 2022

    Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems

  17. 2022

    Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico

  18. 2022

    Cannabinoid modulation of brain activation during volitional regulation of negative affect in trauma-exposed adults

    FavorávelEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)
  19. 2022

    Cannabis use among U.S. military veterans with subthreshold or threshold posttraumatic stress disorder: Psychiatric comorbidities, functioning, and strategies for coping with posttraumatic stress symptoms

    DesfavorávelMetanáliseDorDependência — CannabisAnsiedade+3
  20. 2022

    Case report of a phencyclidine false positive due to lamotrigine use with confirmatory testing

  21. 2022

    Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort

    InconclusivoEnsaio ClínicoAnandamida (AEA)Endocanabinoide (não especificado)+2
  22. 2022

    Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists

  23. 2022

    Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice

    FavorávelEstudo em Animais
  24. 2022

    Does cannabis use predict aggressive or violent behavior in psychiatric populations? A systematic review

    InconclusivoMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+4
  25. 2022

    Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  26. 2022

    Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer

    FavorávelEnsaio Clínico Duplo-CegoDepressãoHidrolase de Amidas de Ácidos Graxos (FAAH)
  27. 2022

    Exercise-induced increases in Anandamide and BDNF during extinction consolidation contribute to reduced threat following reinstatement: Preliminary evidence from a randomized controlled trial

    FavorávelEnsaio ClínicoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  28. 2022

    Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

  29. 2022

    In it together? The case for endocannabinoid–noradrenergic interactions in fear extinction

  30. 2022

    Interactions of Noradrenergic, Glucocorticoid and Endocannabinoid Systems Intensify and Generalize Fear Memory Traces

    DesfavorávelEstudo em AnimaisEndocanabinoide (não especificado)Canabinoides Sintéticos AM-x
  31. 2022

    LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeAyahuasca+6
  32. 2022

    Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments

    FavorávelEstudo em AnimaisCanabinoides Sintéticos AM-x
  33. 2022

    Medical Cannabis and Psychiatric Disorders: Implications for Psychiatric Nurses

    InconclusivoMetanáliseAnsiedadeDoença de AlzheimerDemência+2
  34. 2022

    Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes

    InconclusivoEnsaio ClínicoTranstorno Bipolar
  35. 2022

    Potential Utility of Cannabidiol in Stress-Related Disorders

  36. 2022

    Pregnant People's Perspectives On Cannabis Use During Pregnancy: A Systematic Review and Integrative Mixed-Methods Research Synthesis

    FavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis+7
  37. 2022

    Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada

    FavorávelMetanáliseDorDor — CrônicaDepressão+5
  38. 2022

    Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?

  39. 2022

    The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDisfunção CognitivaTranstornos de Comportamento
  40. 2022

    The association between recreational cannabis use and posttraumatic stress disorder: A systematic review and methodological critique of the literature

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — Cannabis
  41. 2022

    The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study

  42. 2022

    The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+2
  43. 2022

    The role of the cannabinoid system in fear memory and extinction in male and female mice

    InconclusivoEstudo em AnimaisAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  44. 2022

    Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals

  45. 2022

    Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  46. 2022

    United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020

    InconclusivoMetanáliseCâncerAnsiedadeDepressãoAyahuasca+2
  47. 2021

    A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019

    InconclusivoMetanáliseDorCâncerDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+9
  48. 2021

    A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults

  49. 2021

    A scoping review of the use of cannabidiol in psychiatric disorders

    FavorávelMetanálise ClínicaDependência — CannabisAnsiedadePsicose+4
  50. 2021

    Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests

    FavorávelEstudo em AnimaisAnsiedadeTranstornos de Comportamento2-Araquidonoilglicerol (2-AG)
  51. 2021

    Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD

    FavorávelEstudo em Animais
  52. 2021

    Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder

    FavorávelMetanáliseAnsiedadeInsônia e Distúrbios do SonoAnandamida (AEA)
  53. 2021

    Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice

    FavorávelEstudo em Animais
  54. 2021

    Cannabis in the management of PTSD: a systematic review

    InconclusivoMetanálise
  55. 2021

    Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches

    InconclusivoMetanáliseDependência — CannabisAnsiedadePsicose
  56. 2021

    Cannabis use disorder, anger, and violence in Iraq/Afghanistan-era veterans

    DesfavorávelMetanáliseDependência QuímicaDependência — Cannabis
  57. 2021

    Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase

  58. 2021

    Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?

    FavorávelMetanáliseAnsiedadeDepressãoInsônia e Distúrbios do Sono+1
  59. 2021

    Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics

    InconclusivoMetanáliseAnsiedadeEpilepsiaEsclerose Múltipla
  60. 2021

    Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review

  61. 2021

    Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada

    FavorávelMetanáliseDorDor — CrônicaInsônia e Distúrbios do Sono+3
  62. 2021

    Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review

    InconclusivoMetanálise ClínicaAnsiedadeDepressãoTranstorno Bipolar
  63. 2021

    Fear extinction learning and anandamide: an fMRI study in healthy humans

    FavorávelMetanáliseAnsiedadeAnandamida (AEA)
  64. 2021

    Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research

    FavorávelMetanáliseDorDependência QuímicaCâncer+16
  65. 2021

    Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping

  66. 2021

    Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder

    FavorávelEstudo em AnimaisInflamação
  67. 2021

    Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder

  68. 2021

    Moderator effects in a randomized controlled trial of the Common Elements Treatment Approach (CETA) for intimate partner violence and hazardous alcohol use in Zambia

    FavorávelMetanáliseDependência QuímicaDependência — CannabisDepressão+3
  69. 2021

    Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials

    InconclusivoMetanálise ClínicaAnsiedadeEsquizofreniaDependência — Nicotina+6
  70. 2021

    Predictors of substance use in a clinical sample of youth seeking treatment for Trauma-related mental health problems

  71. 2021

    Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases

  72. 2021

    Telephone veteran peer coaching for mental health treatment engagement among rural veterans: The importance of secondary outcomes and qualitative data in a randomized controlled trial

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+1
  73. 2021

    THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways

    InconclusivoEstudo em AnimaisAnsiedade
  74. 2021

    The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice

    InconclusivoEstudo em AnimaisAnsiedadeDisfunção CognitivaCanabigerol (CBG)
  75. 2021

    The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  76. 2021

    The endocannabinoid system - current implications for drug development

  77. 2021

    The endocannabinoid system in the amygdala and modulation of fear

  78. 2021

    The Impact of Co-occurring Post-traumatic Stress Disorder and Substance Use Disorders on Craving: A Systematic Review of the Literature

  79. 2021

    The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD

    FavorávelEnsaio ClínicoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  80. 2021

    The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial

    FavorávelEnsaio Clínico Duplo-Cego
  81. 2021

    Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+7
  82. 2021

    Use of cannabinoids for the treatment of patients with post-traumatic stress disorder

    FavorávelMetanáliseTetraidrocanabinol (THC)THC Farmacêutico
  83. 2021

    VOICES: An efficacious trauma-informed, gender-responsive cannabis use intervention for justice and school-referred girls with lifetime substance use history

  84. 2020

    Associating Emergency Medical Services personnel's workload, trauma exposure, and health with the cortisol, endocannabinoid, and N-acylethanolamine concentrations in their hair

    DesfavorávelEnsaio ClínicoDorAnsiedadeDepressãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+4
  85. 2020

    Cannabinoid Hyperemesis Syndrome: A Case Report and Discussion Regarding Patients with Concurrent Disorders

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDepressão+9
  86. 2020

    Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeEndocanabinoide (não especificado)THC Farmacêutico
  87. 2020

    Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders

    FavorávelMetanálise
  88. 2020

    Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans

    DesfavorávelMetanálise
  89. 2020

    CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim

    FavorávelEstudo em AnimaisDepressãoDisfunção CognitivaTranstornos de Comportamento
  90. 2020

    Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies

    FavorávelMetanálise ClínicaAnsiedade
  91. 2020

    Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals

    FavorávelMetanáliseCâncerAnsiedadeDoenças Cardiovasculares (DCV)+6
  92. 2020

    Inner Engineering Practices and Advanced 4-day Isha Yoga Retreat Are Associated with Cannabimimetic Effects with Increased Endocannabinoids and Short-Term and Sustained Improvement in Mental Health: A Prospective Observational Study of Meditators

  93. 2020

    Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

    FavorávelMetanáliseAnsiedadeDepressãoPsicose+3
  94. 2020

    Prevalence of Common Mental Disorders in South Asia: A Systematic Review and Meta-Regression Analysis

  95. 2020

    Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder

    FavorávelMetanálise
  96. 2020

    The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study

    FavorávelEnsaio Clínico Duplo-CegoDependência — CannabisAnsiedadePsicoseCanabinoide Sintético (não especificado)+5
  97. 2020

    The Long-Term, Prospective, Therapeutic Impact of Cannabis on Post-Traumatic Stress Disorder

    FavorávelMetanálise
  98. 2020

    Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies

    InconclusivoMetanáliseDorDependência QuímicaInflamação+6
  99. 2020

    Therapeutic potential of ayahuasca in grief: a prospective, observational study

    FavorávelEnsaio ClínicoAnsiedadeDepressãoDisfunção CognitivaAyahuasca+1
  100. 2019

    Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms

    FavorávelMetanáliseDorAnsiedadeDepressão+4
  101. 2019

    Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review

    InconclusivoMetanáliseDorAnsiedadeDor — Crônica+1
  102. 2019

    Cannabidiol (CBD) use in psychiatric disorders: A systematic review.

    InconclusivoMetanáliseAnsiedadePsicose
  103. 2019

    Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series

    FavorávelMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+3
  104. 2019

    Cannabinoid interventions for PTSD: Where to next?

    FavorávelMetanálise
  105. 2019

    Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential

    DesfavorávelMetanáliseAnsiedadeDepressãoTranstorno Bipolar
  106. 2019

    Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood

    DesfavorávelEstudo em AnimaisAnsiedade
  107. 2019

    Delta-9-tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states

    DesfavorávelEstudo em Animais
  108. 2019

    Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians

    FavorávelMetanáliseDepressãoTentativa de Suicídio
  109. 2019

    Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies

    InconclusivoMetanáliseDependência — CannabisDependência — ÁlcoolEsquizofrenia+2
  110. 2019

    Endocannabinoid System Components as Potential Biomarkers in Psychiatry

  111. 2019

    Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system

    FavorávelMetanáliseAnsiedadeEndocanabinoide (não especificado)
  112. 2019

    Influence of Δ9-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans

  113. 2019

    Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder

    FavorávelMetanáliseEndocanabinoide (não especificado)
  114. 2019

    Post-traumatic stress and marijuana outcomes: The mediating role of marijuana protective behavioral strategies

    InconclusivoMetanálise
  115. 2019

    Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing

    DesfavorávelEnsaio Clínico Duplo-Cego
  116. 2019

    Priority Considerations for Medicinal Cannabis-Related Research

    FavorávelMetanáliseDorCâncerAnsiedade+16
  117. 2019

    The use of cannabinoids for sleep: A critical review on clinical trials

  118. 2019

    Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

    FavorávelMetanáliseAnsiedadeDepressãoEpilepsia+3
  119. 2019

    Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

    FavorávelMetanáliseTHC Farmacêutico
  120. 2018

    (+)-Borneol suppresses conditioned fear recall and anxiety-like behaviors in mice

    FavorávelEstudo em AnimaisAnsiedadeMedicina Mente-Corpo
  121. 2018

    A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders

  122. 2018

    Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.

  123. 2018

    Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.

    FavorávelEstudo em AnimaisCanabinoides Sintéticos WIN-xOutros Compostos Relacionados
  124. 2018

    Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.

    FavorávelMetanáliseEndocanabinoide (não especificado)
  125. 2018

    Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+6
  126. 2018

    Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice.

  127. 2018

    Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder.

    FavorávelEnsaio ClínicoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  128. 2018

    Residual effects of cannabis use on attentional bias towards fearful faces

    DesfavorávelMetanálise
  129. 2018

    The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+7
  130. 2017

    Cannabidiol Regulation Of Emotion And Emotional Memory Processing: Relevance For Treating Anxiety-related And Substance Abuse Disorders

    FavorávelMetanáliseAnsiedade
  131. 2017

    Endocannabinoid signalling modulates susceptibility to traumatic stress exposure

    FavorávelEstudo em AnimaisAnsiedadeDepressãoTranstorno Bipolar2-Araquidonoilglicerol (2-AG)+1
  132. 2017

    Influence of childhood trauma on diagnosis and substance use in first-episode psychosis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+7
  133. 2017

    Medical Cannabinoids in Children and Adolescents: A Systematic Review.

    FavorávelMetanáliseDorEpilepsiaNáusea e Vômito+2
  134. 2017

    Medical cannabis and mental health: A guided systematic review.

    FavorávelMetanálise
  135. 2016

    Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction.

    FavorávelEstudo em AnimaisAnsiedade
  136. 2016

    Cannabis - the Israeli perspective

  137. 2016

    Effectiveness Of Cannabidiol Oil For Pediatric Anxiety And Insomnia As Part Of Posttraumatic Stress Disorder: A Case Report

    FavorávelMetanáliseAnsiedadeInsônia e Distúrbios do Sono
  138. 2016

    Endocannabinoid concentrations in hair are associated with PTSD symptom severity.

    FavorávelEnsaio ClínicoEndocanabinoide (não especificado)Outros Compostos Relacionados
  139. 2016

    FAAH Gene Variation Moderates Stress Response And Symptom Severity In Patients With Posttraumatic Stress Disorder And Comorbid Alcohol Dependence

  140. 2015

    An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials

    FavorávelMetanáliseAnsiedadeAnandamida (AEA)Endocanabinoide (não especificado)+1
  141. 2015

    Cannabidiol as a Potential Treatment for Anxiety Disorders.

    FavorávelMetanáliseAnsiedadeTOC
  142. 2015

    Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials

    FavorávelMetanálise ClínicaDorDor — CrônicaEsclerose MúltiplaTetraidrocanabinol (THC)+5
  143. 2015

    FAAH genetic variation enhances fronto-amygdala function in mouse and human

    FavorávelEnsaio ClínicoAnsiedadeHidrolase de Amidas de Ácidos Graxos (FAAH)
  144. 2015

    The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.

    FavorávelEnsaio Clínico Duplo-Cego
  145. 2014

    Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing

    FavorávelEstudo em AnimaisCanabinoides Sintéticos AM-xCanabinoides Sintéticos WIN-x
  146. 2014

    Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.

  147. 2014

    Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses

    FavorávelEstudo em AnimaisAnsiedade2-Araquidonoilglicerol (2-AG)Canabinoides Sintéticos CP-x
  148. 2014

    Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder

  149. 2013

    Reductions in Circulating Endocannabinoid Levels in Individuals with Post-Traumatic Stress Disorder Following Exposure to the World Trade Center Attacks

    FavorávelEnsaio ClínicoAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  150. 2013

    The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD).

  151. 2012

    Antidepressant activity of Litsea glaucescens essential oil: Identification of β-pinene and linalool as active principles

    FavorávelEstudo LaboratorialDorAnsiedadeDepressãoMedicina Mente-Corpo+6
  152. 2012

    Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug

    FavorávelMetanáliseAnsiedadeTOC
  153. 2012

    Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.

    FavorávelMetanálise
  154. 2012

    Phase II Trial on the Effects of Silexan in Patients With Neurasthenia, Post-Traumatic Stress Disorder or Somatization Disorder

    FavorávelEnsaio ClínicoAnsiedade
  155. 2012

    Role of the endocannabinoid system in extinction of fear memories: lessons from animal studies

  156. 2009

    Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress on the Conditioning and Extinction of Inhibitory Avoidance.

    FavorávelEstudo em AnimaisCanabinoides Sintéticos AM-xCanabinoides Sintéticos WIN-x
  157. 2009

    The endocannabinoid system and the treatment of mood and anxiety disorders.

    FavorávelMetanáliseAnsiedadeDepressãoTranstorno Bipolar
  158. 2009

    The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).

    FavorávelEnsaio ClínicoCanabinoide Sintético (não especificado)
  159. 2008

    Cannabinoid modulation of amygdala reactivity to social signals of threat in humans

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  160. 2007

    Exposure to terrorism and Israeli youths' cigarette, alcohol, and cannabis use

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+1
  161. 2002

    The endogenous cannabinoid system controls extinction of aversive memories

    FavorávelEstudo em AnimaisCanabinoides Sintéticos SR-x

Continue por aqui

Perguntas frequentes

Quantos estudos sobre tept estão indexados no acervo?
São 161 estudos, publicados entre 2002 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 90 · Estudo em Animais: 25 · Ensaio Clínico: 22 · Ensaio Clínico Duplo-Cego: 16 · Metanálise Clínica: 7 · Estudo Laboratorial: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 116 favoráveis, 24 inconclusivos e 21 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. TEPT — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/tept/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). TEPT — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/tept/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.